Biotechnology BioMarin to Host First Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, April 27, at 4:30pm ET April 13, 2022
Biotechnology Allogene Therapeutics Publishes Preclinical Data on ALLO-316, an AlloCAR T(TM) Candidate Targeting CD70 for the Treatment of Renal Cell Carcinoma, at AACR’s Annual Meeting and in Cancer Research Journal April 13, 2022
Biotechnology ChemoCentryx Reports Pharmacokinetic and Pharmacodynamic Results from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at American Association for Cancer Research (AACR) Annual Meeting 2022 April 13, 2022
Biotechnology BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS April 13, 2022
Biotechnology Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader April 13, 2022
Search
biotech stock market
